Patents and Applications

CGI has submitted several patent applications related to the use of FHACT® (FISH based HPV-Associated Cancer Test).

CGI has a strong and growing portfolio in molecular-focused patents for the diagnosis, prognosis and risk stratification of difficult-to-treat cancers. Our patents are based on unique algorithms that take into account multiple chromosomal regions associated with particular disease outcomes or treatment decision.

Methods for Detecting Human Papilloma Virus-Associated Cancers.

  • US 13/227,027. Pub. Aug. 9, 2012. – Non-Provisional Application
  • US 13/474,111. Pub. Sept. 6, 2012. – Non-Provisional Application
  • PCT/US2011/050681. Pub. March 15, 2012. – Foreign Counterpart Application

Methods of Analyzing Chromosomal Translocations Using Fluorescence In Situ Hybridization (FISH).

  • US Issued Patent 7,585,964. Filed May 15, 2002. – Seminal Patent
  • US Issued Patent 7,964,345. Filed April 5, 2005. – US Divisional Patent
  • Canada 2,447,320. Pub. Nov. 21, 2002. – Foreign Counterpart Patent

Panel for the Detection and Differentiation of Renal Cortical Neoplasms.

  • US 11/932,422. Pub. April 30, 2009. – Notice of Allowance, Oct. 16, 2013
  • Europe 08844570.5. Pub. May 7, 2009. – Foreign Counterpart Application

Tool for Diagnosis and Prognosis of Mature B-Cell Neoplasms.

  • US 12/980,480. Filed Dec. 29, 2010. – Notice of Allowance, Sept. 21, 2013
  • US 13/475,034. Filed May 18, 2012 – Notice of Allowance, Sept. 13, 2013
  • Europe 10803548.6. Pub. Nov. 7, 2012 – Foreign Counterpart Application
  • India 6657/DELNP/2012. Filed Dec. 29, 2010. – Foreign Counterpart Application
  • Canada 2,785,656. Filed Dec. 29, 2010. – Foreign Counterpart Application

Methods and Tools for the Diagnosis of Female Gynecological Cancers and Precancers.

  • US 61/581,350. Filed Dec. 29, 2011. – Provisional Patent Application

Methods and Tools for the Diagnosis and Prognosis of Urogenital Cancers.

  • US 61/765,678. Filed Feb. 15, 2013. – Provisional Patent Application